Allogene Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
All right. Good afternoon, everyone, from the JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst. And it's my pleasure to introduce our next company, Allogene Therapeutics and CEO, David Chang. Please note that following this presentation, we'll have a Q&A session where you have the ability to submit questions via your conference portal.
So with that, David, thanks for being here today, and let me turn things over to you.
Cory, thank you very much for the introduction, and happy new year. Good afternoon. I'm David Chang, CEO and Co-Founder of Allogene, a company dedicated in leading the next revolution in cell therapy.
If we can go to Slide 3? It's great to kick off 2021, updating our investors and supporters about the progresses at Allogene and how we intend to continue to grow Allogene to success throughout
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |